Micafungin Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-729

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 63323-729). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Mic17 0000 01)

Chemical structure diagram of the active ingredient Micafungin Sodium, showing its molecular bonds and arrangement of atoms as part of the drug molecule.*

FDA Label Image

Fresenius Kabi (Mic17 0000 02)

FDA Label Image

Principal Display Panel – Micafungin For Injection 50 mg – Vial Label (Mic17 0000 03)

Micafungin for Injection 50 mg per vial label for intravenous use, lyophilized powder for solution by Fresenius Kabi USA, LLC. The label includes dosage strength (50 mg/vial), drug information, storage instructions, barcode, lot and expiration placeholders, and a pull tab for opening. It indicates single dose vial and prescription only.*

FDA Label Image

Principal Display Panel – Micafungin For Injection 50 mg – Individual Carton (Mic17 0000 04)

Packaging label for Micafungin for Injection, 50 mg per vial, a lyophilized powder for intravenous injection. The label includes dosage information, storage instructions, reconstitution directions, and warnings to discard unused portions. The product is manufactured by Fresenius Kabi USA, LLC. The label features barcodes and branding in blue and white with detailed preparation instructions and the NDC number 63323-728-01.*

FDA Label Image

Principal Display Panel – Micafungin For Injection 50 mg – Shelf Carton (Mic17 0000 05)

Micafungin 50 mg per vial packaging label for injection, lyophilized powder for intravenous infusion only. The label indicates 10 single dose vials per package. It includes storage, reconstitution, and handling instructions. Labeler is Fresenius Kabi USA, LLC, with their logo and contact information displayed.*

FDA Label Image

Principal Display Panel – Micafungin For Injection 100 mg – Vial Label (Mic17 0000 06)

Micafungin for Injection 100 mg per vial lyophilized powder label for intravenous use by Fresenius Kabi USA, LLC. The label includes dosing information, storage instructions to keep at 25°C with allowed excursions, protection from light, and details about the single-dose vial. Barcodes and batch details space are also visible.*

FDA Label Image

Principal Display Panel – Micafungin For Injection 100 mg – Individual Carton (Mic17 0000 07)

Packaging label for Micafungin for Injection, 100 mg per vial, a lyophilized powder for solution. The label includes storage instructions, sterility and reconstitution details, barcodes, and the Fresenius Kabi USA, LLC logo. It specifies the product is for intravenous infusion only, single dose vial, and made in India.*

FDA Label Image

Principal Display Panel – Micafungin For Injection 100 mg – Shelf Carton (Mic17 0000 08)

Packaging label for Micafungin for Injection 100 mg per vial, a lyophilized powder for intravenous infusion. The label indicates the product is supplied as 10 single dose vials of 100 mg each. Manufacturer is Fresenius Kabi USA, LLC. The label includes storage instructions, preparation details, and the NDC 63323-729-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.